Yes, but only if you meet certain conditions and have a doctor prescribe it for you.
After October 1st 2017 CBD Oil (Full spectrum CBD Oil extract) was classified as Schedule 4. Schedule 4, items must be prescribed and supplied by a Pharmacy. Prescribing Doctors need registration under the Safe Access Scheme. Products need registration with the TGA for use in a particular Therapeutic use.
There are two main ways doctors can get medical cannabis for their patients - through the Special Access Scheme (SAS) or as an Authorised Prescriber. The SAS provides for the importation and supply of unapproved therapeutic medication for a single patient, on a case-by-case basis.
There are currently 23 Authorised Prescribers in Australia*, according to the Therapeutic Goods Administration (TGA). 21 of those doctors are based in New South Wales, and there are two in Queensland. All of these doctors are paediatric neurologists. They are authorised specifically to prescribe to children with neurological conditions. That means patients with other conditions, for example terminal cancer, cannot access medical cannabis through these authorised prescribers.
Patients have had to seek CBD oil + related products through websites online with the direction of their doctors + medical professionals.
It’s been over two years since legislation was passed to set up a system of legal cultivation and production of cannabis products for medicinal use. But, despite the Office of Drug Control (ODC) having now issued 35 cannabis - related licences, there’s still no domestic product available.
The situation in Australia is similar to that seen in some U.S. States where medical cannabis is technically legal, but so severely restricted in various ways that most patients’ best option is to patronize the black market.
It’s been over two years since legislation was passed to set up a system of legal cultivation and production of cannabis products for medicinal use. But, despite the Office of Drug Control (ODC) having now issued 35 cannabis-related licences, there’s still no domestic product available. In February last year, minister Hunt launched a fast-track medicinal cannabis importation scheme to cover the delay in local product availability. This imported medicine is now stockpiled in warehouses, as only 525 patients, out of an estimated 100,000 who use cannabis, have been permitted access. And on top of all this, the Turnbull government has twice blocked rapid access to imported products to the terminally ill since November 2016.
*As of 01/03/2017